Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHAEL LOTFI

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1811994296
CMS profile
173037
Location
WEST PALM BEACH, FL

General Payments · PY2018–2024

$3,004.75

  • Reported across 111 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$964.86

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $964.86 37

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $425.88 15
PY2019 $576.99 13
PY2020 $220.62 6
PY2021 $168.98 9
PY2022 $152.49 8
PY2023 $494.93 23
PY2024 $964.86 37

Payment records · PY2024 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $24.46 07/15/2024 Food and Beverage Undisputed 01/23/2026 1115883272 CMS
Amgen Inc. $35.24 11/15/2024 Food and Beverage Undisputed 01/23/2026 1115883259 CMS
Amgen Inc. $27.41 11/15/2024 Food and Beverage Undisputed 01/23/2026 1115883265 CMS
Ardelyx, Inc. $23.04 04/29/2024 Food and Beverage Undisputed 01/23/2026 1146692934 CMS
Ardelyx, Inc. $20.66 08/19/2024 Food and Beverage Undisputed 01/23/2026 1146692936 CMS
Ardelyx, Inc. $22.12 12/09/2024 Food and Beverage Undisputed 01/23/2026 1146692938 CMS
AstraZeneca Pharmaceuticals LP $26.91 03/11/2024 Food and Beverage Undisputed 01/23/2026 1104738419 CMS
AstraZeneca Pharmaceuticals LP $27.90 05/20/2024 Food and Beverage Undisputed 01/23/2026 1105613289 CMS
AstraZeneca Pharmaceuticals LP $14.80 08/09/2024 Food and Beverage Undisputed 01/23/2026 1105512339 CMS
AstraZeneca Pharmaceuticals LP $28.59 09/23/2024 Food and Beverage Undisputed 01/23/2026 1104239739 CMS
AstraZeneca Pharmaceuticals LP $23.19 11/25/2024 Food and Beverage Undisputed 01/23/2026 1104515604 CMS
Bayer Healthcare Pharmaceuticals Inc. $26.61 02/26/2024 Food and Beverage Undisputed 01/23/2026 1086131336 CMS
Bayer Healthcare Pharmaceuticals Inc. $16.51 05/10/2024 Food and Beverage Undisputed 01/23/2026 1086249330 CMS
Bayer Healthcare Pharmaceuticals Inc. $34.91 11/04/2024 Food and Beverage Undisputed 01/23/2026 1086226732 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.28 02/02/2024 Food and Beverage Undisputed 01/23/2026 1118166434 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.48 06/07/2024 Food and Beverage Undisputed 01/23/2026 1118166436 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $24.17 08/16/2024 Food and Beverage Undisputed 01/23/2026 1118166438 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $24.36 10/07/2024 Food and Beverage Undisputed 01/23/2026 1118166440 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $30.79 12/16/2024 Food and Beverage Undisputed 01/23/2026 1118166442 CMS
CALLIDITAS THERAPEUTICS US INC. $22.09 07/29/2024 Food and Beverage Undisputed 01/23/2026 1141519437 CMS
CALLIDITAS THERAPEUTICS US INC. $124.99 07/30/2024 Food and Beverage Undisputed 01/23/2026 1141519509 CMS
CALLIDITAS THERAPEUTICS US INC. $5.40 11/25/2024 Food and Beverage Undisputed 01/23/2026 1141528061 CMS
Fresenius USA Marketing, Inc. $23.63 01/26/2024 Food and Beverage Undisputed 01/23/2026 1154200732 CMS
Lilly USA, LLC $14.14 01/22/2024 Food and Beverage Undisputed 01/23/2026 1135185161 CMS
Lilly USA, LLC $20.81 03/30/2024 Food and Beverage Undisputed 01/23/2026 1135171824 CMS
Lilly USA, LLC $19.76 06/03/2024 Food and Beverage Undisputed 01/23/2026 1135227109 CMS
Novo Nordisk Inc $23.07 01/19/2024 Food and Beverage Undisputed 01/23/2026 1096610570 CMS
Novo Nordisk Inc $23.90 04/22/2024 Food and Beverage Undisputed 01/23/2026 1097313611 CMS
Novo Nordisk Inc $21.15 07/22/2024 Food and Beverage Undisputed 01/23/2026 1097303024 CMS
Novo Nordisk Inc $23.23 09/09/2024 Food and Beverage Undisputed 01/23/2026 1096920444 CMS
Novo Nordisk Inc $13.15 09/12/2024 Food and Beverage Undisputed 01/23/2026 1096926382 CMS
Novo Nordisk Inc $21.66 10/28/2024 Food and Beverage Undisputed 01/23/2026 1097801271 CMS
Novo Nordisk Inc $12.49 11/26/2024 Food and Beverage Undisputed 01/23/2026 1096909853 CMS
Novo Nordisk Inc $12.63 12/23/2024 Food and Beverage Undisputed 01/23/2026 1097471447 CMS
Otsuka America Pharmaceutical, Inc. $26.00 08/12/2024 Food and Beverage Undisputed 01/23/2026 1118932196 CMS
Travere Therapeutics, Inc. $59.99 05/01/2024 Food and Beverage Undisputed 01/23/2026 1149892778 CMS
Vifor Pharma, Inc. $26.34 03/25/2024 Food and Beverage Undisputed 01/23/2026 1124035864 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.